
Accurate, rapid pathogen identification is critical for research breakthroughs and epidemic surveillance in complex respiratory infections. Our Respiratory Pathogen Detection Panel series, powered by Next-Generation Sequencing (NGS) technology, delivers robust solutions from broad-spectrum screening to precise typing – enabling efficient infection resolution and pathogen evolution tracking.
This Respiratory Pathogen Panel research tool overcomes symptom-based and culture limitations by simultaneously detecting nucleic acids from broad respiratory viruses and bacteria in one sample. It provides definitive identification of specific causative agents, including co-infections, pathogens missed by conventional methods, and potential strain differentiation.

Engineered for research efficiency, this panel generates critical results within hours and offers scalable testing—from focused targets to broad pathogen screens. This significantly reduces time-to-answer for pathogen identification versus conventional culture techniques, streamlining data acquisition and interpretation.
Explore Our Respiratory Pathogen Panels:
| Cat. No. | Product Name | Brief Description | Inquiry | Basket |
|---|---|---|---|---|
| PNP003 | Multi-Respiratory Pathogen Kit | Multi-Respiratory Pathogen Kit detects & genotypes nearly 100 respiratory pathogens (viruses like influenza, bacteria, fungi, mycoplasma, chlamydia) via hybridization capture or PCR enrichment. It enables co-detection, differentiates 200+ subtypes, tracks variants, and offers >99% coverage with customizable primers/probes for emerging threats, AMR, and virulence genes | ||
| PNP004 | CDAmp™ MTBC+NTM Panel kit | CDAmp™ MTBC+NTM Panel is Multiplex PCR solution that detects MTBC & 169 NTM species plus 49 drug resistance mutations across 14 anti-TB drugs in one assay. Enables comprehensive TB research and clinical management. | ||
| PNRP110 | CDCAP 200 Respiratory Pathogen Panel Kit | A target enrichment panel based on hybridization-capture protocols for next generation sequencing (NGS) on Illumina platforms, enabling to detection of over 200 respiratory pathogen, including 42 Viruses, 187 Bacteria and 53 Fungi, in a fast, accurate and safe workflow. Allows for widespread identification, relevant mutations and variants analysis and profiling associated antimicrobial resistance (AMR) targets. |
Please submit a detailed description of your project. We will provide you with a customized project plan to meet your research requests. You can also send emails directly to for inquiries.
Please fill out the form below: ×